A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma
University of Waterloo · Juravinski Cancer Centre · +2 more institutions
Abstract
The use of adjuvant chemotherapy to treat adults with localized resectable soft-tissue sarcoma remains controversial. The objective of this systematic review was to update the 1997 meta-analysis of randomized controlled trials (RCTs) to reassess the efficacy of doxorubicin-based chemotherapy with respect to recurrence and survival.
A comprehensive literature search was performed to identify RCTs of adjuvant chemotherapy for adult patients diagnosed with localized resectable soft-tissue sarcoma. Two reviewers independently assessed eligibility and quality of the studies using a modified version of the Detsky Quality Scale. The outcome measures were local, distant, and overall recurrence and survival calculated through the fixed effect or random effect model.
Citation impact
- FWCI
- 26.84
- Percentile
- 100%
- References
- 30
Authors
6- NPNabeel Pervaiz
University of Waterloo
- NCNigel Colterjohn
Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University
- FFForough Farrokhyar
Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University
- RTRichard Tozer
Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University
- AFA Figueredo
Juravinski Cancer Centre, Hamilton Health Sciences, McMaster University
Topics & keywords
- Medicine
- Soft tissue sarcoma
- Ifosfamide
- Chemotherapy
- Sarcoma
- Doxorubicin
- Oncology
- Randomized controlled trial
- Good health and well-being